{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:39:48Z","timestamp":1769971188663,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,26]],"date-time":"2012-02-26T00:00:00Z","timestamp":1330214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s11064-012-0729-x","type":"journal-article","created":{"date-parts":[[2012,2,25]],"date-time":"2012-02-25T01:26:40Z","timestamp":1330133200000},"page":"1436-1441","source":"Crossref","is-referenced-by-count":48,"title":["Serum Iron, Vitamin B12 and Folic Acid Levels in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"37","author":[{"given":"Gulizar","family":"Madenci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sule","family":"Bilen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berna","family":"Arli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Saka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fikri","family":"Ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,26]]},"reference":[{"key":"729_CR1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1471-4159.2002.01118.x","volume":"83","author":"BA Faucheux","year":"2002","unstructured":"Faucheux BA, Martin ME, Beaumont C, Hunot S, Hauw JJ, Agid Y, Hirsch EC (2002) Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson\u2019s disease. J Neurochem 83:320\u2013330","journal-title":"J Neurochem"},{"issue":"6","key":"729_CR2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/mds.20826","volume":"21","author":"G Logroscino","year":"2006","unstructured":"Logroscino G, Chen H, Wing A, Ascherio A (2006) Blood donations, iron stores, and risk of Parkinson\u2019s disease. Mov Disord 21(6):835\u2013838","journal-title":"Mov Disord"},{"key":"729_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/713803493","volume":"48","author":"F Yantiri","year":"1999","unstructured":"Yantiri F, Andersen JK (1999) The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. IUBMB Life 48:139\u2013141","journal-title":"IUBMB Life"},{"issue":"1","key":"729_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03033302","volume":"9","author":"D Berg","year":"2006","unstructured":"Berg D, Hochstrasser H, Schweitzer KJ, Riess O (2006) Disturbance of iron metabolism in Parkinson\u2019s disease-ultrasonography as a biomarker. Neurotoxic Res 9(1):1\u201313","journal-title":"Neurotoxic Res"},{"issue":"11","key":"729_CR5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1515\/CCLM.2007.307","volume":"45","author":"B Foglieni","year":"2007","unstructured":"Foglieni B, Ferrari F, Goldwurm S, Santambrogio P, Castiglioni E, Sessa M, Volont\u00e8 MA, Lalli S, Gali C, Wang X, Connor J, Sironi F, Canesi M, Biasiotto G, Pezzoli G, Levi S, Ferrari M, Arosio P, Cremonesi L (2007) Analysis of ferritin genes in Parkinson disease. Clin Chem Lab Me 45(11):1450\u20131456","journal-title":"Clin Chem Lab Me"},{"key":"729_CR6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/01.wnl.0000225050.57553.6d","volume":"67","author":"LML Lau","year":"2006","unstructured":"Lau LML, Koudstaal PJ, Witteman JCM, Hoffman A, Breteler MMB (2006) Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology 67:315\u2013318","journal-title":"Neurology"},{"issue":"1","key":"729_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/187152708783885101","volume":"7","author":"GA Qureshi","year":"2008","unstructured":"Qureshi GA, Qureshi A, Devrajani BR, Chippa MA, Syed SA (2008) Is the deficiency of vitamin B12 related to oxidative stress and neurotoxicity in Parkinson\u2019s patients? CNS Neurol Disord Drug Targets 7(1):20\u201327","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"729_CR8","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","volume":"42","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Ben-Shlomo Y, Daniel SE (1992) What features improves accuracy of clinical diagnosis in Parkinson\u2019s disease. A clinical pathological study. Neurology 42:1142\u20131146","journal-title":"Neurology"},{"key":"729_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"729_CR10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.49.3.714","volume":"49","author":"G Logroscino","year":"1997","unstructured":"Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, LoIacono N, Cote L, Mayeux R (1997) Altered systemic iron metabolism in Parkinson\u2019s disease. Neurology 49:714\u2013717","journal-title":"Neurology"},{"key":"729_CR11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.50.4.1138","volume":"50","author":"K Marder","year":"1998","unstructured":"Marder K, Logroscino G, Tang M-X, Graziano J, Cote L, Louis E, Alfaro B, Mejia H, Slavkovich V, Mayeux R (1998) Systemic iron metabolism and mortality from Parkinson\u2019s disease. Neurology 50:1138\u20131140","journal-title":"Neurology"},{"issue":"1","key":"729_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1471-4159.1990.tb08814.x","volume":"55","author":"DT Dexter","year":"1990","unstructured":"Dexter DT, Carayon A, Vidailhet M, Ruberg M, Agid F, Agid Y, Lees AJ, Wells FR, Jenner P, Marsden CD (1990) Decreased ferritin levels in brain in Parkinson\u2019s disease. J Neurochem 55(1):16\u201320","journal-title":"J Neurochem"},{"issue":"9","key":"729_CR13","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/j.1537-2995.2009.02207.x","volume":"49","author":"BJ Bryant","year":"2009","unstructured":"Bryant BJ, Hopkins JA, Arceo SM, Leitman SF (2009) Evaluation of low red blood cell mean corpuscular volume in an apheresis donor population. Transfusion 49(9):1971\u20131976","journal-title":"Transfusion"},{"key":"729_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11011-009-9139-4","volume":"24","author":"EF Santos","year":"2009","unstructured":"Santos EF, Busanello ENB, Miglioranza A, Zanatta \u00c2, Barchak AG, Vargas CR, Saute J, Rosa C, Carrion MJ, Camargo D, Dalbem A, Costa JC, Miguel SRPS, Rieder CRM, Wajner M (2009) Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson\u2019s disease. Metab Brain Dis 24:257\u2013269","journal-title":"Metab Brain Dis"},{"issue":"4","key":"729_CR15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/aje\/kwh213","volume":"160","author":"H Chen","year":"2004","unstructured":"Chen H, Zhang SM, Schwarzschild MA, Hern\u00e1n MA, Logroscino G, Willett WC, Ascherio A (2004) Folate intake and risk of Parkinson\u2019s disease. Am J Epidemiol 160(4):368\u2013375","journal-title":"Am J Epidemiol"},{"issue":"12","key":"729_CR16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1301\/002966402320964089","volume":"60","author":"JW Miller","year":"2002","unstructured":"Miller JW (2002) Homocysteine, folate deficiency, and Parkinson\u2019s disease. Nutr Rev 60(12):410\u2013413","journal-title":"Nutr Rev"},{"issue":"13","key":"729_CR17","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.22705","volume":"24","author":"M Barichella","year":"2009","unstructured":"Barichella M, Cereda E, Pezzoli G (2009) Major nutritional issues in the management of Parkinson\u2019s disease. Mov Disord 24(13):1881\u20131892","journal-title":"Mov Disord"},{"key":"729_CR18","first-page":"101","volume":"60","author":"N Hattori","year":"2000","unstructured":"Hattori N, Shimura H, Kubo S, Wang M, Shimizu N, Tanaka K, Mizuno Y (2000) Importance of familial Parkinson\u2019s disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson\u2019s disease. J Neural Transm Suppl 60:101\u2013116","journal-title":"J Neural Transm Suppl"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0729-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-012-0729-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-012-0729-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:34:41Z","timestamp":1559349281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-012-0729-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,26]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1007\/s11064-012-0729-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,26]]}}}